| 标题 |
[高分]
Design and rationale for a phase 3 trial of admilparant (BMS-986278), an oral lysophosphatidic acid receptor 1 antagonist, in patients with idiopathic pulmonary fibrosis: ALOFT-IPF |
| 网址 | |
| DOI | |
| 其它 |
已有摘要,但是需要最新发布的全文:Pneumologie 2026 80 (S32) Supplement 1 期刊:Pneumologie 作者:T Maher; M S Wijsenbeek; M Kreuter; A Fischer; S Kim; et al 出版日期:2026-03-05 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)